• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

MorphoSys AG - Articles and news items


MorphoSys provides update on MOR202 in multiple myeloma

Industry news / 23 September 2015 / Victoria White

The Company said that the clinical data from a Phase 1/2a study confirm the very good overall safety profile of the fully human HuCAL antibody…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +